KOBO BIOTECH LIMITED (KOBO.BO)
INR 4.1
(3.54%)
INR 4.1
(3.54%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 2.03 Million | 8.74 Million | 936.22 Million | -79.69 Million | -143.99 Million | 65.47 Million |
| Net Income | -49.28 Million | -55.53 Million | -152.25 Million | -192.31 Million | -210.06 Million | -244.59 Million |
| Depreciation & Amortization | 40.71 Million | 40.71 Million | 46.06 Million | 56.37 Million | 58.78 Million | 61.45 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 156 Thousand | 23.56 Million | 1.04 Billion | 56.25 Million | 7.28 Million | 104.17 Million |
| Other non-cash items | 10.45 Million | 57.37 Million | -984.22 Million | 104.59 Million | 117.56 Million | 245.49 Million |
| Investing Cash Flow | - | - | 250.9 Million | - | -27.11 Thousand | -36.18 Thousand |
| Investments in PPE | -2.03 Million | - | - | - | -27.11 Thousand | -36.18 Thousand |
| Acquisitions | - | - | 128.92 Million | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | 121.93 Million | - | - | - |
| Other Investing Activities | - | - | 52 Thousand | - | - | - |
| Financing Cash Flow | -1.5 Million | -8.74 Million | -1.2 Billion | 94.01 Million | 144 Million | -65.45 Million |
| Debt repayment | -9.46 Million | -8.74 Million | -1.19 Billion | -94.01 Million | -144 Million | -78.98 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 7.96 Million | -8.74 Million | -3.31 Million | 3.21 Million | -144.74 Million | -144.43 Million |
| Accounts receivables | -130 Thousand | -1.56 Million | 806.75 Million | 8.14 Million | -26.79 Million | -17.79 Million |
| Accounts payables | 10.45 Million | 25.62 Million | -82.78 Million | - | - | - |
| Inventory | - | - | 352.38 Million | - | - | 21.84 Million |
| Other working capital | 286 Thousand | -505 Thousand | -33.92 Million | 48.1 Million | 7.28 Million | 82.32 Million |
| Cash at beginning of period | 1.26 Million | 835 Thousand | 15.16 Million | 1.27 Million | 1.29 Million | 882.94 Thousand |
| Cash at end of period | 1.8 Million | 841 Thousand | 835 Thousand | 15.16 Million | 1.27 Million | 1.29 Million |
| Capital Expenditure | -2.03 Million | - | - | - | -27.11 Thousand | -36.18 Thousand |
| Effect of forex changes on cash | - | - | 192.00 | - | 17.43 Thousand | - |
| Net cash flow / Change in cash | 536 Thousand | 6000.00 | -14.33 Million | 13.89 Million | -17.45 Thousand | 412.77 Thousand |
| Free Cash Flow | - | 8.74 Million | 936.22 Million | -79.69 Million | -144.01 Million | 65.43 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -13.29 Thousand | -12.56 Thousand | -49.28 Million | -12.31 Thousand | -12.15 Thousand | -12.25 Thousand |
| Depreciation & Amortization | - | - | 40.71 Million | 10.27 Million | 10.19 Million | 10.12 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | 10.61 Million | - | - | - |
| Other non-cash items | 13.29 Thousand | 12.56 Thousand | 71.1 Million | 12.31 Thousand | 12.15 Thousand | 12.25 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | - | - | -1.5 Million | - | - | - |
| Debt repayment | - | - | -7.96 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | -9.46 Million | - | - | - |
| Accounts receivables | - | - | -130 Thousand | - | - | - |
| Accounts payables | - | - | 10.45 Million | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | 286 Thousand | - | - | - |
| Cash at beginning of period | - | - | 841 Thousand | 842 Thousand | 12.99 Million | 841 Thousand |
| Cash at end of period | - | - | 1.8 Million | 21.39 Million | 842 Thousand | -12.25 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | 965 Thousand | 20.55 Million | -12.15 Million | -13.09 Million |
| Free Cash Flow | - | - | 2.03 Million | 20.55 Million | -12.15 Million | -12.25 Million |
BTBT
PME
3407
NAE
4673
PFE